Back to Search

JOHN WO, MD

MD

Gastroenterology Physician

NPI: 1972596906IndividualAccepts Medicare

Specialties, Licenses & Credentials

Gastroenterology PhysicianPrimary

Internal Medicine — Gastroenterology

Code: 207RG0100X

32553(KY)01069927A(IN)

CMS Specialties

PrimaryGASTROENTEROLOGY

Education

VIRGINIA COMMONWEALTH UNIVERSITY, SCHOOL OF MEDICINE

Class of 1990

Clinical Trials (2)

2
Linked Trials
0
Recruiting
2
With Results

Pharmacokinetics of Immediate-Release vs. Delayed-Release Omeprazole in Gastroparesis

NCT00492622COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR

Effects of Lubiprostone on Small Bowel and Colonic Bacteria: A Correlation Study With Segmental and Whole Gut Transit

NCT00844831COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR

Research & Publications (20)

Pharmacokinetic profile of immediate-release omeprazole in patients with gastro-oesophageal reflux associated with gastroparesis.
PMID 19925497·Aliment Pharmacol Ther·2010
4-observational
Double-blind, placebo-controlled trial with single-dose pantoprazole for laryngopharyngeal reflux.
PMID 16968502·Am J Gastroenterol·2006
2-rct
Effective inhibition of expression of hepatitis B virus genes by DNAzymes.
PMID 15962363·World J Gastroenterol·2005
8-other
Clinical impact of upper endoscopy in the management of patients with gastroesophageal reflux disease.
PMID 15571575·Am J Gastroenterol·2004
8-other
[DNAzymes in vitro inhibit the expression of hepatitis B virus genes].
PMID 12734934·Zhejiang Da Xue Xue Bao Yi Xue Ban·2003
8-other
Hypopharyngeal pH monitoring artifact in detection of laryngopharyngeal reflux.
PMID 12452398·Dig Dis Sci·2002
8-other
Comparison of methylene blue-directed biopsies and conventional biopsies in the detection of intestinal metaplasia and dysplasia in Barrett's esophagus: a preliminary study.
PMID 11522968·Gastrointest Endosc·2001
3-trial
Current medical and surgical treatment options for gastroesophageal reflux disease.
PMID 11105473·J Ky Med Assoc·2000
5-case
Expression of H5N1 influenza virus hemagglutinin protein fused with protein transduction domain in an alphavirus replicon system.
PMID 19646478·J Virol Methods·2010
7-preclinical
Chemoprevention of metaplasia initiation and carcinogenic progression to esophageal adenocarcinoma by resveratrol supplementation.
PMID 19398904·Anticancer Drugs·2009
7-preclinical

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Request Appointment

Contact & Hours

Address
550 UNIVERSITY BLVD STE 1710
INDIANAPOLIS, IN 46202

Locations (2)

Practice Location

550 UNIVERSITY BLVD STE 1710, INDIANAPOLIS, IN
(317) 944-0980

Practice Location

1701 N SENATE BLVD, INDIANAPOLIS, IN
(888) 484-3258

Quick Facts

NPI
1972596906
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
2
Locations
2
Years in Practice
36
Clinical Trials
2
Publications
20

Are you this provider?

Claim Your Profile